drugset / Trial / NCT00758407

Methylphenidate Treatment of Cancer-Related Fatigue

NCT00758407

Phase 2/3 Completed 66 enrolled Medice Arzneimittel Pütter GmbH & Co KG
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.

Timeline

Start
2006-08
Primary completion
2010-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule